Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study

Yıl: 2023 Cilt: 28 Sayı: 3 Sayfa Aralığı: 456 - 465 Metin Dili: İngilizce DOI: 10.5578/flora.20239716 İndeks Tarihi: 28-10-2023

Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study

Öz:
Introduction: The objective of this study was to compare the risk factors and mortality rates of candidemia among patients with and without COVID-19 in the intensive care units (ICU). Materials and Methods: This study is a retrospective multicenter observational study, in ICUs of 12 hospitals (eight tertiary and four secondary hospitals) in Türkiye. All adult patients (>18 years) hospitalized in ICUs and developed candidemia between 01.01.2020- 31.12.2021 were included. The following data were collected: age, gender, nasopharyngeal swab SARS-CoV-2 PCR test, species of Candida (Candida albicans or non-albicans Candida), comorbidities, ICU stay, antibiotic use, corticosteroid, and anti-cytokine therapy, central venous catheter (CVC), abdominal surgery, parenteral nutrition, mechanical ventilation (MV), other cultures isolated Candida spp., echocardiography (ECO), mortality. Data from patients with or without COVID-19 were compared. Results: A total of 188 patients, 66 COVID-19 and 122 non-COVID-19, were included in the study. The median age of the patients was 69.5 and there were no differences between the groups. 185 (98.4%) patients had a history of antibiotic use. Sixteen patients, all from the COVID-19 group, had a history of anti-cytokine therapy. Corticosteroid use was higher in COVID-19 patients (p< 0.001). Intraabdominal surgery was higher in the non-COVID-19 group (p< 0.014). C. albicans was isolated from 36.7% of total patients and the remaining were non-albicans Candida species. The overall mortality was higher in COVID-19 patients (p= 0.014). Alzheimer’s and malignancies were higher in non-COVID-19 patients. Intraabdominal surgery, MV, and CVC were higher in tertiary care hospitals whereas parenteral nutrition was higher in secondary care hospitals. Conclusion: Immunosuppressive treatments administered to COVID-19 patients pose a risk in terms of candidemia. Risk factors may differ between secondary and tertiary care hospitals. Preventable risk factors should be determined on a hospital basis and appropriate infection control measures should be taken.
Anahtar Kelime: Candidemia COVID-19 Risk factors Intensive care unit

Pandemi Sürecinde COVID-19 ve COVID-19 Dışı Tanılar ile Yoğun Bakım Ünitelerinde Takip Edilen Hastaların Kandidemi Açısından Risk Faktörlerinin Analizi: Çok Merkezli Bir Çalışma

Öz:
Giriş: Bu çalışmanın amacı, yoğun bakım ünitelerinde (YBÜ) COVID-19 olan ve olmayan hastalarda kandidemi risk faktörlerini ve ölüm oranlarını araştırmaktır. Materyal ve Metod: Çalışma Türkiye’de sekizi üçüncü basamak dördü ikinci basamak olmak üzere 12 merkezde yürütülen çok merkezli retrospektif gözlemsel bir çalışmadır. 01.01.2020 ve 31.12.2021 tarihleri arasında 18 yaş ve üzeri yoğun bakımda takip edilen ve kandidemi gelişen tüm hastalar çalışmaya dahil edildi. Hastaların yaş, cinsiyet, nazofarengeal SARS-CoV-2 PCR sonuçları, üreyen kandida türü (Candida albicans veya non-albicans Candida olarak), komorbiditeleri, YBÜ yatış süresi, antibiyotik kullanımı, kortikosteroid ve anti-sitokin tedavi, santral venöz kateter (SVK), abdominal cerrahi, parenteral beslenme, mekanik ventilasyon (MV), kandida üreyen diğer kültürler, ekokardiografi (EKO) ve mortalite bilgileri kaydedildi. Veriler COVID-19 olan ve olmayan hastalar arasında karşılaştırıldı. Bulgular: Çalışmaya 66 COVID-19 ve 122 COVID-19 dışı olmak üzere toplam 188 hasta dahil edildi. Hastaların ortanca yaşı 69.5 olup gruplar arasında fark bulunmadı. Tüm hastaların 185’inde (%98.4) antibiyotik kullanım öyküsü vardı. Tamamı COVID-19 grubunda yer alan 16 hastanın anti-sitokin tedavi öyküsü vardı. COVID-19 hastalarında kortikosteroid kullanımı daha yüksek iken (p< 0.001) COVID-19 olmayan grupta karın içi cerrahi daha yüksek saptandı (p< 0.014). Tüm suşların %36.7’si C. albicans iken, geriye kalanlar non-albicans Candida türleriydi. Genel mortalite, COVID-19 hastalarında daha yüksek bulundu (p= 0.014). Alzheimer ve malignite, COVID-19 olmayan hastalarda daha yüksekti. Üçüncü basamak hastanelerde intraabdominal cerrahi, MV ve SVK daha yüksek iken, ikinci basamak hastanelerde parenteral beslenme anlamlı oranda yüksek saptandı. Sonuç: COVID-19 hastalarında uygulanan immünsüpresif tedaviler kandidemi açısından risk oluşturmaktadır. Risk faktörleri ikinci ve üçüncü basamak hastaneler arasında farklılık gösterebilir. Önlenebilir risk faktörleri hastane bazında belirlenmeli ve uygun infeksiyon kontrol önlemleri alınmalıdır.
Anahtar Kelime: Kandidemi COVID-19 Risk faktörleri Yoğun bakım ünitesi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Livermore DM. Antibiotic resistance during and beyond COVID-19. JAC-Antimicrobial Resistance 2021;3:5-16. https://doi.org/10.1093/jacamr/dlab052
  • 2. Togun T, Kampmann B, Stoker NG, Lipman M. Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes. Ann Clin Microbiol Antimicrob 2020;19:1-6. https://doi.org/10.1186/s12941-020- 00363-1
  • 3. Torner N. Collateral effects of COVID-19 pandemic emergency response on worldwide immunizations. Vacunas (English Edition) 2020;21:73. https://doi.org/10.1016/j. vacune.2020.10.006
  • 4. Zhou P, Liu Z, Chen Y, Xiao Y, Huang X, Fan XG. Bacterial and fungal infections in COVID-19 patients: A matter of concern. Infect Control Hosp Epidemiol 2020;41:1124-5. https://doi.org/10.1017/ice.2020.156
  • 5. Fakih MG, Bufalino A, Sturm L, Huang RH, Ottenbacher A, et al. Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): The urgent need to refocus on hardwiring prevention efforts. Infect Control Hosp Epidemiol 2022;43:26-31. https://doi. org/10.1017/ice.2021.70
  • 6. Baker MA, Sands KE, Huang SS, Kleinman K, Septimus EJ, CDC Prevention Epicenters Program. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections. Clin Infect Dis 2022;74:1748-54. https://doi. org/10.1093/cid/ciab688
  • 7. Thoma R, Seneghini M, Seiffert SN, Vuichard Gysin D, Scanferla G, Haller S, et al. The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: Report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature. Antimicrob Resist Infect Control 2022;11:1-11. https://doi. org/10.1186/s13756-022-01052-8
  • 8. Jin LS, Fisher D. MDRO transmission in acute hospitals during the COVID-19 pandemic. Curr Opin Infect Dis 2021;34:365-71. https://doi.org/10.1097/ QCO.0000000000000735
  • 9. Arastehfar A, Shaban T, Zarrinfar H, Roudbary M, Ghazanfari M, Hedayati MT, et al. Candidemia among Iranian patients with severe COVID-19 admitted to ICUs. J Fungi 2021;7:280. https://doi.org/10.3390/jof7040280
  • 10. Nucci M, Barreiros G, Guimarães LF, Deriquehem VAS, Castiñeiras AC, Nouér SA. Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic. Mycoses 2021;64:152-6. https://doi.org/10.1111/ myc.13225
  • 11. Riche CV, Cassol R, Pasqualotto AC. Is the frequency of candidemia increasing in COVID-19 patients receiving corticosteroids? J Fungi 2020;6:286. https://doi.org/10.3390/ jof6040286
  • 12. Kayaaslan B, Eser F, Kaya Kalem A, Bilgic Z, Asilturk D, Hasanoglu I, et al. Characteristics of candidemia in COVID-19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non-COVID-19 patients. Mycoses 2021;64:1083-91. https://doi.org/10.1111/ myc.13332
  • 13. Vijay S, Bansal N, Rao BK, Veeraraghavan B, Rodrigues C, Wattal C, et al. Secondary infections in hospitalized COVID-19 patients: Indian experience. Infect Drug Resist 2021;14:1893. https://doi.org/10.2147/IDR.S299774
  • 14. Seagle EE, Jackson BR, Lockhart SR, Georgacopoulos O, Nunnally NS, Roland J, et al. The landscape of candidemia during the coronavirus disease 2019 (COVID-19) pandemic. Clin Infect Dis 2022;74:802-11. https://doi. org/10.1093/cid/ciab562
  • 15. Mastrangelo A, Germinario BN, Ferrante M, Frangi C, Li Voti R, Muccini C, et al. Candidemia in COVID-19 patients: Incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls. Clin Infect Dis 2020;30:ciaa1594. https://doi.org/10.1093/cid/ ciaa1594
  • 16. Arastehfar A, Carvalho A, Nguyen MH, Hedayati MT, Netea MG, Perlin DS, et al. COVID-19-associated candidiasis (CAC): An underestimated complication in the absence of immunological predispositions?. J Fungi 2020;6:211. https://doi.org/10.3390/jof6040211
  • 17. Villanueva-Lozano H, Treviño-Rangel RJ, González GM, Ramírez-Elizondo MT, Lara-Medrano R, Aleman-Bocanegra MC, et al. Outbreak of Candida auris infection in a COVID-19 hospital in Mexico. Clin Microbiol Infect 2021;27:813-6. https://doi.org/10.1016/j.cmi.2020.12.030
  • 18. Prestel C, Anderson E, Forsberg K, Lyman M, de Perio MA, Kuhar D, Dotson NQ. Candida auris outbreak in a COVID-19 specialty care unit-Florida, July-August 2020. Morb Mortal Wkly Rep 2021;70:56. https://doi.org/10.15585/ mmwr.mm7002e3
  • 19. de Almeida Jr JN, Francisco EC, Hagen F, Brandão IB, Pereira FM, Presta Dias PH, et al. Emergence of Candida auris in Brazil in a COVID-19 intensive care unit. J Fungi 2021;7:220. https://doi.org/10.3390/jof7030220
  • 20. Vaseghi N, Sharifisooraki J, Khodadadi H, Nami S, Safari F, Ahangarkani F, Morovati H. Global prevalence and subgroup analyses of Coronavirus disease (COVID-19) associated Candida auris infections (CACa): A systematic review and meta-analysis. Mycoses 2022;65:683-703. https:// doi.org/10.1111/myc.13471
  • 21. Vinayagamoorthy K, Pentapati KC, Prakash H. Prevalence, risk factors, treatment and outcome of multidrug resistance Candida auris infections in coronavirus disease (COVID-19) patients: A systematic review. Mycoses 2022;65:613-24. https://doi.org/10.1111/myc.13447
  • 22. Gong X, Luan T, Wu X, Li G, Qiu H, Kang Y, Zang B. Invasive candidiasis in intensive care units in China: Risk factors and prognoses of Candida albicans and non-albicans Candida infections. Am J Infect Control 2016;44:e59-e63. https://doi.org/10.1016/j.ajic.2015.11.028
  • 23. Playford EG, Marriott D, Nguyen Q, Chen S, Ellis D, Slavin M. Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp. Crit Care Med 2008;36:2034-9. https://doi.org/10.1097/CCM. 0b013e3181760f42
APA karakök t, Gözükara M, Uygun Kizmaz Y, DEMİR Y, Törüyenler Coşkunpınar M, Altun Demircan Ş, ARSLAN Y, İrkören P, ALP GÖKER E, DOĞAN A, tuzun t, SEVİM Ş, Cakir Y, IŞIK M, MERMUTLUOĞLU Ç, Azap A, KINIKLI S, Tekin S, Şimşek-Yavuz S, Öner S (2023). Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study. , 456 - 465. 10.5578/flora.20239716
Chicago karakök taliha,Gözükara Melih Gaffar,Uygun Kizmaz Yesim,DEMİR YAKUP,Törüyenler Coşkunpınar Melike,Altun Demircan Şerife,ARSLAN YUSUF,İrkören Pelin,ALP GÖKER EDA,DOĞAN AHMET,tuzun turkan,SEVİM ŞÜKRAN,Cakir Yasemin,IŞIK Mehmet Emirhan,MERMUTLUOĞLU ÇİĞDEM,Azap Alpay,KINIKLI SAMI,Tekin Suda,Şimşek-Yavuz Serap,Öner Sedef Zeliha Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study. (2023): 456 - 465. 10.5578/flora.20239716
MLA karakök taliha,Gözükara Melih Gaffar,Uygun Kizmaz Yesim,DEMİR YAKUP,Törüyenler Coşkunpınar Melike,Altun Demircan Şerife,ARSLAN YUSUF,İrkören Pelin,ALP GÖKER EDA,DOĞAN AHMET,tuzun turkan,SEVİM ŞÜKRAN,Cakir Yasemin,IŞIK Mehmet Emirhan,MERMUTLUOĞLU ÇİĞDEM,Azap Alpay,KINIKLI SAMI,Tekin Suda,Şimşek-Yavuz Serap,Öner Sedef Zeliha Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study. , 2023, ss.456 - 465. 10.5578/flora.20239716
AMA karakök t,Gözükara M,Uygun Kizmaz Y,DEMİR Y,Törüyenler Coşkunpınar M,Altun Demircan Ş,ARSLAN Y,İrkören P,ALP GÖKER E,DOĞAN A,tuzun t,SEVİM Ş,Cakir Y,IŞIK M,MERMUTLUOĞLU Ç,Azap A,KINIKLI S,Tekin S,Şimşek-Yavuz S,Öner S Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study. . 2023; 456 - 465. 10.5578/flora.20239716
Vancouver karakök t,Gözükara M,Uygun Kizmaz Y,DEMİR Y,Törüyenler Coşkunpınar M,Altun Demircan Ş,ARSLAN Y,İrkören P,ALP GÖKER E,DOĞAN A,tuzun t,SEVİM Ş,Cakir Y,IŞIK M,MERMUTLUOĞLU Ç,Azap A,KINIKLI S,Tekin S,Şimşek-Yavuz S,Öner S Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study. . 2023; 456 - 465. 10.5578/flora.20239716
IEEE karakök t,Gözükara M,Uygun Kizmaz Y,DEMİR Y,Törüyenler Coşkunpınar M,Altun Demircan Ş,ARSLAN Y,İrkören P,ALP GÖKER E,DOĞAN A,tuzun t,SEVİM Ş,Cakir Y,IŞIK M,MERMUTLUOĞLU Ç,Azap A,KINIKLI S,Tekin S,Şimşek-Yavuz S,Öner S "Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study." , ss.456 - 465, 2023. 10.5578/flora.20239716
ISNAD karakök, taliha vd. "Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study". (2023), 456-465. https://doi.org/10.5578/flora.20239716
APA karakök t, Gözükara M, Uygun Kizmaz Y, DEMİR Y, Törüyenler Coşkunpınar M, Altun Demircan Ş, ARSLAN Y, İrkören P, ALP GÖKER E, DOĞAN A, tuzun t, SEVİM Ş, Cakir Y, IŞIK M, MERMUTLUOĞLU Ç, Azap A, KINIKLI S, Tekin S, Şimşek-Yavuz S, Öner S (2023). Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, 28(3), 456 - 465. 10.5578/flora.20239716
Chicago karakök taliha,Gözükara Melih Gaffar,Uygun Kizmaz Yesim,DEMİR YAKUP,Törüyenler Coşkunpınar Melike,Altun Demircan Şerife,ARSLAN YUSUF,İrkören Pelin,ALP GÖKER EDA,DOĞAN AHMET,tuzun turkan,SEVİM ŞÜKRAN,Cakir Yasemin,IŞIK Mehmet Emirhan,MERMUTLUOĞLU ÇİĞDEM,Azap Alpay,KINIKLI SAMI,Tekin Suda,Şimşek-Yavuz Serap,Öner Sedef Zeliha Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi 28, no.3 (2023): 456 - 465. 10.5578/flora.20239716
MLA karakök taliha,Gözükara Melih Gaffar,Uygun Kizmaz Yesim,DEMİR YAKUP,Törüyenler Coşkunpınar Melike,Altun Demircan Şerife,ARSLAN YUSUF,İrkören Pelin,ALP GÖKER EDA,DOĞAN AHMET,tuzun turkan,SEVİM ŞÜKRAN,Cakir Yasemin,IŞIK Mehmet Emirhan,MERMUTLUOĞLU ÇİĞDEM,Azap Alpay,KINIKLI SAMI,Tekin Suda,Şimşek-Yavuz Serap,Öner Sedef Zeliha Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, vol.28, no.3, 2023, ss.456 - 465. 10.5578/flora.20239716
AMA karakök t,Gözükara M,Uygun Kizmaz Y,DEMİR Y,Törüyenler Coşkunpınar M,Altun Demircan Ş,ARSLAN Y,İrkören P,ALP GÖKER E,DOĞAN A,tuzun t,SEVİM Ş,Cakir Y,IŞIK M,MERMUTLUOĞLU Ç,Azap A,KINIKLI S,Tekin S,Şimşek-Yavuz S,Öner S Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi. 2023; 28(3): 456 - 465. 10.5578/flora.20239716
Vancouver karakök t,Gözükara M,Uygun Kizmaz Y,DEMİR Y,Törüyenler Coşkunpınar M,Altun Demircan Ş,ARSLAN Y,İrkören P,ALP GÖKER E,DOĞAN A,tuzun t,SEVİM Ş,Cakir Y,IŞIK M,MERMUTLUOĞLU Ç,Azap A,KINIKLI S,Tekin S,Şimşek-Yavuz S,Öner S Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi. 2023; 28(3): 456 - 465. 10.5578/flora.20239716
IEEE karakök t,Gözükara M,Uygun Kizmaz Y,DEMİR Y,Törüyenler Coşkunpınar M,Altun Demircan Ş,ARSLAN Y,İrkören P,ALP GÖKER E,DOĞAN A,tuzun t,SEVİM Ş,Cakir Y,IŞIK M,MERMUTLUOĞLU Ç,Azap A,KINIKLI S,Tekin S,Şimşek-Yavuz S,Öner S "Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study." Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, 28, ss.456 - 465, 2023. 10.5578/flora.20239716
ISNAD karakök, taliha vd. "Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study". Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi 28/3 (2023), 456-465. https://doi.org/10.5578/flora.20239716